Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Colorectal Neoplasms and FGFR1[original query] |
|---|
| Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center. European journal of cancer (Oxford, England : 1990) 2013 Oct 49 (15): 3076-82. Wiesweg Marcel, Ting Saskia, Reis Henning, Worm Karl, Kasper Stefan, Tewes Mitra, Welt Anja, Richly Heike, Meiler Johannes, Bauer Sebastian, Hense Jörg, Gauler Thomas C, Köhler Jens, Eberhardt Wilfried E, Darwiche Kaid, Freitag Lutz, Stamatis Georgios, Breitenbücher Frank, Wohlschlaeger Jeremias, Theegarten Dirk, Derks Cordula, Cortes-Incio Diana, Linden Gabriele, Skottky Silke, Lütkes Peter, Dechêne Alexander, Paul Andreas, Markus Peter, Schmid Kurt W, Schuler Mart |
| Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer. American journal of cancer research 2015 5 (1): 72-86. Lee Choong-Kun, Lee Myung Eun, Lee Won Suk, Kim Jeong Min, Park Kyu Hyun, Kim Tae Soo, Lee Kang Young, Ahn Joong Bae, Chung Hyun Cheol, Rha Sun You |
| Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response. Oncotarget 2016 Apr . Li Zhe-Zhen, Wang Feng, Zhang Zi-Chen, Wang Fang, Zhao Qi, Zhang Dong-Sheng, Wang Feng-Hua, Wang Zhi-Qiang, Luo Hui-Yan, He Ming-Ming, Wang De-Shen, Jin Ying, Ren Chao, Qiu Miao-Zhen, Ren Jian, Pan Zhi-Zhong, Li Yu-Hong, Shao Jiao-Yong, Xu Rui-H |
| Comprehensive genomic sequencing detects important genetic differences between right-sided and left-sided colorectal cancer. Oncotarget 2017 Nov 8 (55): 93567-93579. Shimada Yoshifumi, Kameyama Hitoshi, Nagahashi Masayuki, Ichikawa Hiroshi, Muneoka Yusuke, Yagi Ryoma, Tajima Yosuke, Okamura Takuma, Nakano Masato, Sakata Jun, Kobayashi Takashi, Nogami Hitoshi, Maruyama Satoshi, Takii Yasumasa, Hayashida Tetsu, Takaishi Hiromasa, Kitagawa Yuko, Oki Eiji, Konishi Tsuyoshi, Ishida Fumio, Kudo Shin-Ei, Ring Jennifer E, Protopopov Alexei, Lyle Stephen, Ling Yiwei, Okuda Shujiro, Ishikawa Takashi, Akazawa Kohei, Takabe Kazuaki, Wakai Toshifu |
| [A Case of Metastatic Colon Cancer Dramatically Affected by Anti-EGFR Antibody Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy 2016 Nov 43 (12): 1800-1802. Yagi Ryoma, Shimada Yoshifumi, Miura Kohei, Tajima Yosuke, Okamura Takuma, Nakano Masato, Ichikawa Hiroshi, Nagahashi Masayuki, Sakata Jun, Kobayashi Takashi, Kameyama Hitoshi, Wakai Toshifumi, Nogami Hitoshi, Maruyama Satoshi, Takii Yasuma |
| Copy number profiles of paired primary and metastatic colorectal cancers. Oncotarget 2018 Jan 9 (3): 3394-3405. Kawamata Futoshi, Patch Ann-Marie, Nones Katia, Bond Catherine, McKeone Diane, Pearson Sally-Ann, Homma Shigenori, Liu Cheng, Fennell Lochlan, Dumenil Troy, Hartel Gunter, Kobayasi Nozomi, Yokoo Hideki, Fukai Moto, Nishihara Hiroshi, Kamiyama Toshiya, Burge Matthew E, Karapetis Christos S, Taketomi Akinobu, Leggett Barbara, Waddell Nicola, Whitehall Vic |
| Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis. Cancer medicine 2019 Nov . Ye Zu-Lu, Qiu Miao-Zhen, Tang Tao, Wang Fang, Zhou Yi-Xin, Lei Meng-Jie, Guan Wen-Long, He Cai-Y |
| Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients. International journal of clinical oncology 2019 1 24 (2): 141-152. Gao Xian Hua, Yu Guan Yu, Hong Yong Gang, Lian Wei, Chouhan Hanumant, Xu Yi, Liu Lian Jie, Bai Chen Guang, Zhang W |
| Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment. Therapeutic advances in medical oncology 2020 11 12 1758835920965842. Lee Min-Sang, Cho Hee Jin, Hong Jung Yong, Lee Jeeyun, Park Se Hoon, Park Joon Oh, Park Young Suk, Lim Ho Yeong, Kang Won Ki, Cho Yong Beom, Kim Seung T |
| A comprehensive pan-cancer study of fibroblast growth factor receptor aberrations in Chinese cancer patients. Annals of translational medicine 2020 11 8 (20): 1290. Sun Yi, Li Gao, Zhu Wei, He Qiuyan, Liu Yongchang, Chen Xianshan, Liu Juan, Lin Jing, Han-Zhang Han, Yang Zheng, Lizaso Analyn, Xiang Jianxing, Mao Xinru, Liu Hao, Gao Ya |
| Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 8 41 (3): 485-496. Topham James T, O'Callaghan Chris J, Feilotter Harriet, Kennecke Hagen F, Lee Young S, Li Weimin, Banks Kimberly C, Quinn Katie, Renouf Daniel J, Jonker Derek J, Tu Dongsheng, Chen Eric X, Loree Jonathan |
| Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience. JCO precision oncology 2022 6 6 e2100289. Gerratana Lorenzo, Movarek Michael, Wehbe Firas, Katam Neelima, Mahalingam Devalingam, Donahue Jeannine, Shah Ami, Chae Young K, Mulcahy Mary, Tsarwhas Dean, Villaflor Victoria, Kalyan Aparna, Hussein Maha, Patel Jyoti, Chandra Sunandana, Platanias Leonidas C, Gradishar William, Cristofanilli Massimo, Behdad Am |
| Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA (ctDNA) in Routine Clinical Practice. Oncology 2024 9 1-24. Shaheenah Dawood, Nippun Sandhir, Marwan Akasheh, Maroun El Khoury, Sonia Otsmane, Muath Alnassar, Omalkhair Abulkhair, Fadi Farhat, Steve Ols |
- Page last reviewed:Feb 1, 2024
- Content source: